Bio-Rad to Participate at the 38th Annual J.P. Morgan Healthcare Conference on January 13
January 02 2020 - 4:15PM
Business Wire
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader
of life science research and clinical diagnostic products, today
announced that Norman Schwartz, President and CEO; Andrew Last,
Executive Vice President and COO; and Ilan Daskal, Executive Vice
President and CFO will participate in the 38th Annual J.P. Morgan
Healthcare Conference on Monday, January 13, at 11 AM (Pacific
Time), at the Westin St. Francis Hotel, San Francisco,
California.
A link to the live webcast of the presentation will be available
in the Investor Relations area of our website at
www.bio-rad.com.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global
leader in developing, manufacturing, and marketing a broad range of
innovative products for the life science research and clinical
diagnostic markets. With a focus on quality and customer service
for over 65 years, our products advance the discovery process and
improve healthcare. Our customers are university and research
institutions, hospitals, public health and commercial laboratories,
biotechnology, pharmaceutical, as well as applied laboratories that
include food safety and environmental quality. Founded in 1952,
Bio-Rad is based in Hercules, California, and has a global network
of operations with more than 8,000 employees worldwide. Bio-Rad had
revenues exceeding $2.2 billion in 2018. For more information,
please visit www.bio-rad.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200102005128/en/
Bio-Rad Laboratories, Inc. Tina Cuccia, Corporate Communications
510-724-7000 tina_cuccia@bio-rad.com
Bio Rad Laboratories (NYSE:BIO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bio Rad Laboratories (NYSE:BIO)
Historical Stock Chart
From Sep 2023 to Sep 2024